IDEAL_ANSWER:
- Dapagliflozin (ForxigaÂ®) is the first in a novel class of glucose-lowering agents known as sodium-glucose co-transporter-2 (SGLT2) inhibitors and is used in the treatment of patients with type 2 diabetes.

EXACT_ANSWER:
- Treatment of patients with type 2 diabetes.